UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000012173 |
|---|---|
| Receipt number | R000014230 |
| Scientific Title | Phase II study of dasatinib (DA) in combination with chemotherapy and allogeneic stem cell transplantation (SCT) for newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia by Japan Acute Leukemia Study Group (JALSG Ph+ALL213) |
| Date of disclosure of the study information | 2013/11/01 |
| Last modified on | 2022/01/30 12:52:55 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2013/10/30 20:12:50 | ||
| 2 | Update | 2013/12/14 10:10:49 | Recruitment status |
|
| 3 | Update | 2016/08/26 11:26:28 | Name of primary person or sponsor Organization Category of Funding Organization |
|
| 4 | Update | 2016/08/26 11:27:41 | Recruitment status |
|
| 5 | Update | 2020/06/25 13:24:27 | Recruitment status Date of IRB Last follow-up date |
|
| 6 | Update | 2021/07/21 04:57:08 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Organization Organization Address Address Tel |
|
| 7 | Update | 2021/07/21 05:03:33 | Number of participants that the trial has enrolled Results Delayed Results Delay Reason Results Delay Reason |
|
| 8 | Update | 2022/01/30 12:52:55 | URL related to results and publications Number of participants that the trial has enrolled Results Results Results date posted Date of the first journal publication of results Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures Plan to share IPD Plan to share IPD IPD sharing Plan description IPD sharing Plan description |
